Patents full text · MLC-0201
CPC subclass A61P
Specific therapeutic activity of chemical compounds or medicinal preparations
| No. | Publication | Title | Published | Assignee |
|---|---|---|---|---|
| 1 | US2026104418A1 | Claudin18 antibodies and methods of treating cancer | 2026-04-16 | |
| 2 | US2026103696A1 | Compositions and methods for adoptive cell therapy for cancer | 2026-04-16 | |
| 3 | US2026103539A1 | Multispecific antigen binding proteins for tumor-targeting of NK cells and use thereof | 2026-04-16 | |
| 4 | US2026103524A1 | Nkg2d-nkp46 cell adapter molecule and use thereof | 2026-04-16 | |
| 5 | US2026103514A1 | Antibodies that specifically bind cldn6 or cd3 and bispecific antibodies that specifically bind cldn6 and cd3 | 2026-04-16 | |
| 6 | US2026103507A1 | Nucleic acid construct and use thereof | 2026-04-16 | |
| 7 | US2026103494A1 | Gene therapy treatment | 2026-04-16 | |
| 8 | US2026103444A1 | 8-hydroxyquinoline compound and use thereof | 2026-04-16 | |
| 9 | US2026102507A1 | Camptothecin derivative for treating or preventing cancer and antibody-drug conjugate thereof | 2026-04-16 | |
| 10 | US2026102485A1 | Neutralizing anti-tl1a monoclonal antibodies | 2026-04-16 | |
| 11 | US2026102454A1 | Dual acting polymers in an osmotic film for topical application to treat inflammatory diseases and cytokine release syndrome | 2026-04-16 | |
| 12 | US2026102446A1 | Use of oncolytic viruses, alone or in combination with a checkpoint inhibitor, for the treatment of cancer | 2026-04-16 | |
| 13 | US2026102391A1 | Inhibition of a tripartite vor protein complex in multicellular organisms | 2026-04-16 | |
| 14 | US2026102371A1 | Process for synthesizing a formulation of galangin-loaded hydrogel for expedited wound healing | 2026-04-16 | |
| 15 | US2026102360A1 | Nano2 dodecafluoropentane emulsion as a cardiac arrest therapeutic | 2026-04-16 | |
| 16 | US2022396796A1 | Rna for cancer therapy | 2022-12-15 | CUREVAC AG |
| 17 | US11358956B2 | Compounds containing polysubstituted benzo[d][1,3]oxathiole, benzo[d][1,3]oxathiole 3-oxide or benzo[d][1,3]oxathiole 3,3-dioxide and methods/uses thereof as agonists of G protein-coupled receptor 119 | 2022-06-14 | PRAMANA PHARMACEUTICALS INC |
| 18 | US11191837B2 | Recombinant VWF formulations | 2021-12-07 | TAKEDA PHARMACEUTICALS CO |
| 19 | US11123312B2 | Engaging the cervical spinal cord circuitry to re-enable volitional control of hand function in tetraplegic subjects | 2021-09-21 | UNIV CALIFORNIA |
| 20 | US2021236576A1 | Composition for preventing or treating cancer comprising extracts of anemone raddeana, lonicera species, and aralia elata containing high concentration of antitumor saponins, and method for preparing same | 2021-08-05 | BACK JU YOUN |
| 21 | US2021171552A1 | Phosphoantigen prodrug compounds | 2021-06-10 | UNIV COLLEGE CARDIFF CONSULTANTS LTD |
| 22 | US10994045B2 | Process for making dry and stable hemostatic compositions | 2021-05-04 | BAXTER INT |
| 23 | US10952965B2 | Compositions and methods for drug delivery | 2021-03-23 | RABINOW BARRETT |
| 24 | US10718031B1 | Method and system for matching entities in an auction | 2020-07-21 | WU WAI |
| 25 | US10525059B2 | Pharmaceutical compositions comprising Afatinib | 2020-01-07 | FRESENIUS KABI ONCOLOGY LTD |
| 26 | US10513517B2 | Naphthyridine derivatives as alpha V beta 6 integrin antagonists for the treatment of E.G. fibrotic diseases | 2019-12-24 | GLAXOSMITHKLINE IP DEV LTD |
| 27 | US2019175763A1 | Methods and systems for noninvasive control of brain cells and related vectors and compositions | 2019-06-13 | CALIFORNIA INST OF TECHN |
| 28 | US10265351B2 | Probiotic for infantile colic | 2019-04-23 | AB BIOTICS SA |
| 29 | US10231907B2 | Compositions for improving the health and appearance of skin | 2019-03-19 | ALGENIST HOLDINGS INC |
| 30 | US10137109B2 | Carbazole compounds and therapeutic uses of the compounds | 2018-11-27 | INCURON LLC |
| 31 | US2018273597A1 | Compositions and methods relating to the treatment of diseases | 2018-09-27 | ALFACYTE LTD |
| 32 | US10039820B2 | West nile virus vaccine comprising WN-80E recombinant subunit protein | 2018-08-07 | HAWAII BIOTECH INC |
| 33 | US9745296B2 | Salts, co-crystals, and polymorphs of an anxiolytic compound | 2017-08-29 | BIONOMICS LTD |
| 34 | US9730911B2 | Cannabis extracts and methods of preparing and using same | 2017-08-15 | UNITED CANNABIS CORP |
| 35 | US9700542B2 | Compounds as opioid receptor modulators | 2017-07-11 | JANSSEN PHARMACEUTICA NV |
| 36 | US9650680B2 | MicroRNAs and uses thereof | 2017-05-16 | ROSETTA GENOMICS LTD |
| 37 | US9585838B2 | Production of multivesicular liposomes | 2017-03-07 | HARTOUNIAN HARTOUN |
| 38 | US9541004B2 | Antagonist antibodies against EphB3 | 2017-01-10 | NOVARTIS AG |
| 39 | US9453082B2 | Polysaccharides from prasinococcales | 2016-09-27 | GLYCOMAR LTD |
| 40 | US9439932B2 | Pluripotent cells | 2016-09-13 | CELAVIE BIOSCIENCES LLC |
| 41 | US9421238B2 | Treatment of klebsiella pneumoniae with liposomally formulated glutathione | 2016-08-23 | UNIV EMORY |
| 42 | US9345498B2 | Methods of controlling magnetic nanoparticles to improve vascular flow | 2016-05-24 | PULSE THERAPEUTICS INC |
| 43 | US2016008467A1 | Method for the production of sub-micrometric particles and their theranostic use in oncology with a specific apparatus | 2016-01-14 | MBN NANOMATERIALIA SPA |
| 44 | US2015366933A1 | Treatment of klebsiella pneumoniae with liposomally formulated glutathione | 2015-12-24 | UNIV EMORY |
| 45 | US9108916B2 | Carbazole compounds and therapeutic uses of the compounds | 2015-08-18 | INCURON LLC |
| 46 | US9018160B2 | Peptide tyrosine tyrosine analogues | 2015-04-28 | BLOOM STEPHEN ROBERT |
| 47 | US8961969B2 | Antagonist antibodies against EphB3 | 2015-02-24 | NOVARTIS AG |
| 48 | US8765738B2 | Carbazole compounds and therapeutic uses of the compounds | 2014-07-01 | TUCKER JOHN |
| 49 | US8383769B2 | Peptides for inhibiting chemokine binding to chemokine receptors | 2013-02-26 | BIOKINE THERAPEUTICS LTD |
| 50 | US2013012555A1 | Compounds, Compositions and Methods for the Treatment of Islet Amyloid Polypeptide (IAPP) Accumulation in Diabetes | 2013-01-10 | LAKE THOMAS |
| 51 | US2012245141A1 | Activators of human pyruvate kinase | 2012-09-27 | THOMAS CRAIG J |
| 52 | US8039440B2 | Peptides for inhibiting chemokine binding to chemokine receptors | 2011-10-18 | BIOKINE THERAPEUTICS LTD |
| 53 | US8007842B2 | Composition for inhalation therapy and methods of use | 2011-08-30 | TOWER LAB LTD |
| 54 | US2011171213A1 | Methods for treating pancreatic cancer | 2011-07-14 | HOUHOU LEILA |
| 55 | US2011117086A1 | Monoclonal antibodies to progastrin and their uses | 2011-05-19 | BIOREALITES S A S |
| 56 | US2011002857A1 | Oleaginous pharmaceutical and cosmetic foam | 2011-01-06 | FOAMIX LTD |
| 57 | US7851479B2 | Use of pyrimidinedione derivative for preventing or treating hepatitis C | 2010-12-14 | SAMJIN PHARM CO LTD |
| 58 | US2010008938A1 | Self assembling amphiphilic polymers as antiviral agents | 2010-01-14 | DIWAN ANIL |
| 59 | US2009017090A1 | Devices and methods for delivering active agents to the osteomeatal complex | 2009-01-15 | ARENSDORF PATRICK A |
| 60 | US7429572B2 | Modified fluorinated nucleoside analogues | 2008-09-30 | PHARMASSET INC |
| 61 | US2008045472A1 | Targets for human micro rnas in avian influenza virus (h5n1) genome | 2008-02-21 | COUNCIL SCIENT IND RES |
| 62 | US2007275984A1 | Novel Thieno-Pyridine and Thieno-Pyrimidine Derivatives and Their Use as Positive Allosteric Modulators of Mglur2-Receptors | 2007-11-29 | JANSSEN PHARMACEUTICA NV |
| 63 | US2007082907A1 | Peroxisome proliferator activated receptor modulators | 2007-04-12 | LILLY CO ELI |
| 64 | US2007027150A1 | 2-Amino-quinazolin-5-ones | 2007-02-01 | BELLAMACINA CORNELIA R |
| 65 | US2006094652A1 | Hybrid polypeptides with selectable properties | 2006-05-04 | LEVY ODILE E |
| 66 | US2005287148A1 | Monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma | 2005-12-29 | CHATTERJEE MALAYA |
| 67 | US2005136049A1 | Binding constructs and methods for use thereof | 2005-06-23 | |
| 68 | US2004157853A1 | Thiazolopytimidines and their use as modulators of chemokine receptor activity | 2004-08-12 | |
| 69 | US2003055049A1 | Heteroaromatic bicyclic derivatives useful as anticancer agents | 2003-03-20 | PFIZER |
| 70 | US6524608B2 | Intravesical drug delivery system | 2003-02-25 | POINT BIOMEDICAL CORP |
| 71 | US6417221B1 | Tropane analogs and methods for inhibition of monoamine transport | 2002-07-09 | ORGANIX INC |
| 72 | US6410531B1 | Hepatitis C inhibitor tri-peptides | 2002-06-25 | BOEHRINGER INGELHEIM CA LTD |
| 73 | US6335316B1 | Method for administering acylated insulin | 2002-01-01 | LILLY CO ELI |
| 74 | US6319510B1 | Gum pad for delivery of medication to mucosal tissues | 2001-11-20 | |
| 75 | US6303151B1 | Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment | 2001-10-16 | ROGOSIN INST |
| 76 | US6268207B1 | Enzymatic resolution of 1-amino-2-vinylcyclopropyl caboxylic acid methyl ester | 2001-07-31 | BOEHRINGER INGELHEIM CA LTD |
| 77 | US6264988B1 | Fibrinogen-coated microspheres | 2001-07-24 | HEMOSPHERE INC |
| 78 | US6261820B1 | Fibronolytically active polypeptide | 2001-07-17 | AMGEN INC |
| 79 | US6214805B1 | RNase L activators and antisense oligonucleotides effective to treat RSV infections | 2001-04-10 | US HEALTH |
| 80 | US6149944A | Preparation method for biodegradable polymeric microspheres using solvent extraction and preparation method for microspheres for treating local inflammation using the same | 2000-11-21 | KOREA INST SCI & TECH |
| 81 | US6069231A | PR domain peptides | 2000-05-30 | JOLLA CANCER RES FOUND |
| 82 | US6060057A | Cloning and sequencing of allergens of Dermatophagoides (house dust mite) | 2000-05-09 | IMMULOGIC PHARMA CORP |
| 83 | US5972344A | Banana peel extract composition and method for extraction | 1999-10-26 | |
| 84 | US5962532A | Therapeutic method with capsaicin and capsaicin analogues | 1999-10-05 | |
| 85 | US5910502A | Use of levobupivacaine in paediatric surgery | 1999-06-08 | DARWIN DISCOVERY LTD |
| 86 | US5879672A | Tie-2 ligand 1 | 1999-03-09 | REGENERON PHARMA |
| 87 | US5798115A | Bioresponsive pharmacologically-active polymers and articles made therefrom | 1998-08-25 | |
| 88 | US5780448A | DNA-based vaccination of fish | 1998-07-14 | OTTAWA CIVIC HOSPITAL LOEB RES |
| 89 | US5766571A | Method of treating human breast cancer by administration of radiolabeled antibody and unsaturated fatty acids | 1998-06-16 | CANCER RES FUND OF CONTRACOSTA |
| 90 | US5747034A | Methods and materials for the induction of T cell anergy | 1998-05-05 | CHIRON CORP |
| 91 | US5714468A | Method for reduction of migraine headache pain | 1998-02-03 | |
| 92 | US5667789A | Salicylic acid derivative as a stabilizer for an oil-in-water emulsion | 1997-09-16 | OREAL |
| 93 | US5624949A | Protein kinase C inhibitors | 1997-04-29 | LILLY CO ELI |
| 94 | US5378825A | Backbone modified oligonucleotide analogs | 1995-01-03 | ISIS PHARMACEUTICALS INC |
| 95 | US5116986A | Heteroaromatic amine derivatives | 1992-05-26 | THOMAE GMBH DR K |
| 96 | US5082848A | Substituted 4-aminoquinoline derivatives as gastric acid secretion inhibitors | 1992-01-21 | SMITH KLINE FRENCH LAB |
| 97 | US5080899A | Method of treating pulmonary inflammation | 1992-01-14 | AMERICAN HOME PROD |
| 98 | US5037839A | Pyridine-2,4-and -2,5-dicarboxylic acid amides and medicaments based on these compounds | 1991-08-06 | HOECHST AG |
| 99 | US4831050A | Pyrrolidinyl benzopyrans as hypotensive agents | 1989-05-16 | BEECHAM GROUP PLC |
| 100 | US4303649A | 1-Phenyl-2-aminoethanol derivatives | 1981-12-01 | ICI LTD |
102 records in this listing. Patents full text (MLC-0201). Request the full dataset.